Bio Pharma Dive
MAY 16, 2024
The results, which showed Lilly’s drug was as effective at controlling blood sugar as standard injections, come as Novo Nordisk seeks approval for a competing once-weekly insulin.
Pharmaceutical Technology
MAY 16, 2024
The US National Opioid Settlement is distributing more than $54 billion to communities grappling with the opioid crisis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 16, 2024
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.
Pharmaceutical Technology
MAY 16, 2024
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Melanoma.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 16, 2024
While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.
Pharmaceutical Technology
MAY 16, 2024
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 16, 2024
INZ-701 is under clinical development by Inozyme Pharma and currently in Phase II for Pseudoxanthoma Elasticum (PXE or Gronblad Strandberg Syndrome).
Bio Pharma Dive
MAY 16, 2024
A drug Roche acquired in a buyout of Carmot Therapeutics and that works similarly to Zepbound helped people lose nearly 19% of their body weight in a Phase 1 trial.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 16, 2024
The top 10 destinations led by USA, Germany and Italy accounted for almost 63.3 per cent of India’s Ayush and herbal products during the fiscal year 2023-24. Exports to these 10 countries together stood at $412 million, with a growth of 5.
Pharmaceutical Technology
MAY 16, 2024
IgGenix is planning to initiate a clinical trial later this year investigating its peanut allergy monoclonal antibody IGXN001.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 16, 2024
Have you ever wondered how your brain creates thoughts or why something randomly popped into your head? It may seem like magic – but actually the brain is like a supercomputer inside your head that helps you think, learn and make decisions. Imagine your brain as a busy city with lots of streets and buildings.
Pharmaceutical Technology
MAY 16, 2024
Takeda's new dengue vaccine, TAK-003, has received prequalification from the World Health Organization (WHO).
Rethinking Clinical Trials
MAY 16, 2024
According to a report from the NIH Pragmatic Trials Collaboratory Coordinating Center, journal editors and peer reviewers were familiar with pragmatic clinical trials and their designs and analytic approaches, but they often asked for more information about intervention implementation. The report was published this week in the Living Textbook of Pragmatic Clinical Trials.
Bio Pharma Dive
MAY 16, 2024
The deal is part of a plan by J&J to build a portfolio of “differentiated” bispecific antibodies, an increasingly popular area of drug development.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
MAY 16, 2024
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
Pharmaceutical Technology
MAY 16, 2024
JWTCR-001 is under clinical development by MediGene and currently in Phase I for Solid Tumor.
Pharma Times
MAY 16, 2024
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
Pharmaceutical Technology
MAY 16, 2024
ABP-671 is under clinical development by Jiangsu Atom Bioscience and Pharmaceutical and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure).
Fierce Pharma
MAY 16, 2024
The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. With 18 of the industry’s top 25 companies achieving year-over-year revenue gains, Q1 came close to matching the final quarter of last year, when 21 of the top 25 companies showed increases.
Pharmaceutical Technology
MAY 16, 2024
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Prostate Cancer.
Fierce Pharma
MAY 16, 2024
China-made PD-1 inhibitors just can’t get a clean pass through the FDA. | China-made PD-1 inhibitors continue to struggle at the FDA. This week, the U.S. agency rejected Elevar Therapeutics and Jiangsu Hengrui Pharma's PD-1 combination in liver cancer.
Pharmaceutical Technology
MAY 16, 2024
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Colorectal Cancer.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
MAY 16, 2024
Get to know Kirsten Parr through 12 insightful questions as she shares her experiences and insights while working at IPG Health Medical Communications.
Pharmaceutical Technology
MAY 16, 2024
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Bladder Cancer.
Fierce Pharma
MAY 16, 2024
A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, Denmark, where the drugmaker is currently charting a multi-year expansi | A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, Denmark, where the drugmaker is currently charting a multi-year expansion to boost capacity for its blockbuster diabetes and obesity drugs.
Pharmaceutical Technology
MAY 16, 2024
Amidst congressional action and changes in payer pricing models, experts discuss what must be done for patients to reap benefits.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
MAY 16, 2024
Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.
Pharmaceutical Technology
MAY 16, 2024
Roche’s GLP-1/GIP receptor agonist, which was gained in the Carmot acquisition, showed an 18.8% weight loss in a Phase Ib trial.
pharmaphorum
MAY 16, 2024
Notable biotech financings in the last week include a $120m direct offering for iTeos, and private rounds for Lycia, Attovia, Ajax, and CinDome
Pharmaceutical Technology
MAY 16, 2024
Uniquity is planning Phase II trials in COPD and asthma with TSLP-targeting drug solrikitug that it licensed from MSD
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
306 
Let's personalize your content